Drug maker Boehringer Ingelheim is donating 75,000 doses of rabies vaccine to support the mass vaccination of dogs on the African island nation of Madagascar.
The vaccination campaign is organized by the Global Alliance for Rabies Control and coincides with World Rabies Day on Sept. 28.
“Dog owners in Madagascar want to vaccinate their dogs against rabies, but barriers like cost and access to facilities prevent them from doing so,” said Louis Nel, MSc, Ph.D., the alliance’s executive director.
“Dog-mediated rabies disproportionately affects rural and economically disadvantaged communities. By preventing rabies at its source, we can help protect those who lack access to effective rabies treatment.”
Boehringer Ingelheim reported the donation was part of Shots for Good, a pledge of rabies vaccines for every dose of Purevax, Recombitek and IMRAB vaccine purchased by participating veterinary practices from July 2 to August 10, 2018.